Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (31-40 of 269) with videos related to

Pageof 27
Sort By:
Neuro-Oncology|March 28, 2002
A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastomaGreg D Eley, Jill L Reiter, Ajay Pandita, et al.
Analytical Biochemistry|April 24, 2007
Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cellsEric Mahlum, Deendayal Mandal, Chandralekha Halder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2014
Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brainYu Meng, Istvan Sohar, David E Sleat, et al.
American Journal of Clinical Pathology|October 3, 2017
Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous ProcessCristiane M Ida, Malinda L Butz, Robert B Jenkins, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2008
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402Caterina Giannini, Peter C Burger, Brian A Berkey, et al.
The Lancet. Oncology|March 6, 2009
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic responseMonica M Reinholz, Amy K Bruzek, Daniel W Visscher, et al.
Genes, Chromosomes & Cancer|May 12, 2009
Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulationXiaoke Wang, Rachael L Hulshizer, Michele R Erickson-Johnson, et al.
Genes, Chromosomes & Cancer|October 9, 2004
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomasGaspar Kitange, Anjan Misra, Mark Law, et al.
Mayo Clinic Proceedings|February 13, 2002
HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridizationEdith A Perez, Patrick C Roche, Robert B Jenkins, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
Fusion of HMGA1 to the LPP/TPRG1 intergenic region in a lipoma identified by mapping paraffin-embedded tissuesXiaoke Wang, Renata Q Zamolyi, Hongying Zhang, et al.
Pageof 27

Showing results (31-40 of 269) with videos related to

Sort By:
Pageof 27
Neuro-Oncology|March 28, 2002
A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastomaGreg D Eley, Jill L Reiter, Ajay Pandita, et al.
Analytical Biochemistry|April 24, 2007
Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cellsEric Mahlum, Deendayal Mandal, Chandralekha Halder, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2014
Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brainYu Meng, Istvan Sohar, David E Sleat, et al.
American Journal of Clinical Pathology|October 3, 2017
Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous ProcessCristiane M Ida, Malinda L Butz, Robert B Jenkins, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2008
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402Caterina Giannini, Peter C Burger, Brian A Berkey, et al.
The Lancet. Oncology|March 6, 2009
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic responseMonica M Reinholz, Amy K Bruzek, Daniel W Visscher, et al.
Genes, Chromosomes & Cancer|May 12, 2009
Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulationXiaoke Wang, Rachael L Hulshizer, Michele R Erickson-Johnson, et al.
Genes, Chromosomes & Cancer|October 9, 2004
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomasGaspar Kitange, Anjan Misra, Mark Law, et al.
Mayo Clinic Proceedings|February 13, 2002
HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridizationEdith A Perez, Patrick C Roche, Robert B Jenkins, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
Fusion of HMGA1 to the LPP/TPRG1 intergenic region in a lipoma identified by mapping paraffin-embedded tissuesXiaoke Wang, Renata Q Zamolyi, Hongying Zhang, et al.
Pageof 27